View Press Releases
-
Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials
Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials
Mar 4, 2024
-
FDB and WebMD Ignite Collaborate to Drive Medication Safety and Adherence
FDB and WebMD Ignite Collaborate to Drive Medication Safety and Adherence
Mar 4, 2024
-
STEVENSON SEARCH PARTNERS RECEIVES INVESTMENT TO SPUR GROWTH AS A LEADING TALENT SOLUTIONS PROVIDER IN LIFE SCIENCES
Stevenson Search Partners, a leading worldwide life sciences executive search firm, prepares for growth with investment from Six Sibs Capital. The new funding – announced today - will create greater value as Stevenson Search Partners evolves as a total talent solution company for life sciences.
Mar 4, 2024
-
CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award
CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award 2024 Annual Association of Clinical Data Management (ACDM24) recognizes CluePoints’ improved methodology to proactively identify and address data quality.
Mar 4, 2024
-
UChicago Medicine and the University of Chicago Collaborate with MDClone to Improve Healthcare Data Access for Clinical Care Insights and Research
UChicago Medicine and the University of Chicago Collaborate with MDClone to Improve Healthcare Data Access for Clinical Care Insights and Research
Mar 4, 2024
-
Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform
Synexa Life Sciences has announced the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.
Mar 3, 2024
-
WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges
WCG’s Statistical Consulting Solutions provide statistical support across all stages of clinical trial design and regulatory strategy from protocol reviews to final analyses.
Mar 3, 2024
-
LIQUID STABLE AND NIST VERIFIED CLINICAL REFERENCE MATERIALS FOR LITHIUM AVAILABLE FROM VERICHEM
VERICHEM LABORATORIES now offers two, distinct multi-level test kits of clinical reference materials for the calibration verification of Lithium assays.
Mar 3, 2024
-
AI Chatbots Emerge as a Promising Solution for Accessible Mental Healthcare
Mental health chatbots are surging in popularity due to the growing need for accessible and convenient care.
Feb 29, 2024
-
N4 Pharma’s novel delivery systems, Nuvec® and LipTide®, advance towards commercialisation
-
Creative Biogene Develops Comprehensive Microbial Platform with Streamlined Validation Method
-
IntegrateRNA Announces Comprehensive Services to Support Oligonucleotide Coupling Programs
-
Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics
-
Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services
-
Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics
-
Microbialtec Enhances Industrial Applications with Microbial Enzyme Production
-
Neobe Therapeutics raises over $2m for synthetic biology enabled tumour microenvironment remodelling
Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34M financing round.
Feb 28, 2024
-
Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data
Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images
Feb 26, 2024
-
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
New Kalderos board members bring broad legal, regulatory, and corporate leadership experience across healthcare, biopharmaceutical, and pharmacy industries.
Feb 26, 2024
-
Optibrium Launches a Metabolism Prediction Software Platform Tailored to DMPK Scientists
Optibrium has launched Semeta™, a metabolism prediction platform tailored specifically for drug metabolism and pharmacokinetics (DMPK) scientists. Fundamental to improving a drug’s chance of clinical success, Semeta allows the accurate prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery, with superior precision to comparable software.
Feb 26, 2024